成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart 0 Sign in  

[ CAS No. 122794-99-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 122794-99-4
Chemical Structure| 122794-99-4
Structure of 122794-99-4 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 122794-99-4 ]

Related Doc. of [ 122794-99-4 ]

Alternatived Products of [ 122794-99-4 ]
Product Citations

Product Details of [ 122794-99-4 ]

CAS No. :122794-99-4 MDL No. :MFCD00173362
Formula : C12H10BrNO3 Boiling Point : -
Linear Structure Formula :- InChI Key :IVZIOBTVAJBBAS-UHFFFAOYSA-N
M.W : 296.12 Pubchem ID :689824
Synonyms :

Calculated chemistry of [ 122794-99-4 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 17
Num. arom. heavy atoms : 10
Fraction Csp3 : 0.17
Num. rotatable bonds : 3
Num. H-bond acceptors : 4.0
Num. H-bond donors : 1.0
Molar Refractivity : 67.55
TPSA : 59.42 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.76 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.81
Log Po/w (XLOGP3) : 3.3
Log Po/w (WLOGP) : 2.88
Log Po/w (MLOGP) : 2.0
Log Po/w (SILICOS-IT) : 2.84
Consensus Log Po/w : 2.77

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.99
Solubility : 0.0301 mg/ml ; 0.000102 mol/l
Class : Soluble
Log S (Ali) : -4.22
Solubility : 0.0177 mg/ml ; 0.0000598 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -4.45
Solubility : 0.0105 mg/ml ; 0.0000355 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 1.84

Safety of [ 122794-99-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P305+P351+P338 UN#:N/A
Hazard Statements:H319 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 122794-99-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 122794-99-4 ]

[ 122794-99-4 ] Synthesis Path-Downstream   1~4

  • 2
  • [ 101937-44-4 ]
  • [ 122794-99-4 ]
YieldReaction ConditionsOperation in experiment
100% In diphenylether; at 250℃; for 0.0833333h;microwave irradiation; Preparation of Intermediate 4cIntermediate 3c (330mg, 0 879mmoles) was transferred into a microwave vessel and dissolved in 2 ml of diphenylether The experiment was run at 25O0C for 5 minutes Then, petroleum ether was added and the precipitate formed was collected by filtration 1H-NMR confirmed the structure of the desired compound obtained in quantitative yield
88% With diphenylether;Reflux; To a preheated refluxing di-phenol ether (50m1), was added compound 1 (30.5g, 0.0892mo1) in about 1 5mm. The resulting mixture was continue to heat at reflux until the bubbling stopped in about 1 to 2 hours. After cooling to room temperature, the solid was collected and dried to give ethyl 6-bromo-4-oxo- 1,4-dihydroquinoline-3-carboxylate (compound 2, 25.4g, 88%) as an off white solid.
88% In diphenylether; for 0.25h;Reflux; To a preheated refluxing di-phenol ether (50ml), was added compound 1 (30.5g, 0.0892mol) in about 15min. The resulting mixture was continue to heat at reflux until the bubbling stopped in about 1 to 2 hours. After cooling to room temperature, the solid was collected and dried to give ethyl 6-bromo-4-oxo-l,4-dihydroquinoline-3-carboxylate (compound 2, 25.4g, 88%) as an off white solid.
80% In diphenylether; at 220℃; for 30h; A suspension of 38.4 g of the product from the previous step (112mmol) in 200 ml diphenylether was heated up to 220 C internaltemperature and stirring was continued for 30 h. The reactionmixture was then cooled to room temperature and diluted with200 ml Et2O. The precipitate was isolated by filtration and washedsuccessively with EtOH and Et2O. The filter cake was dried in avacuum oven at 60 C overnight to yield 26.4 g (80%) of the titlecompound as off-white crystalline solid. ESI-MS m/z: 317.7[MNa]
80% In diphenylether; at 220℃; for 30h; A suspension of 38.4 g of the product from the previous step (112mmol) in 200 ml diphenylether was heated up to 220 C internaltemperature and stirring was continued for 30 h. The reactionmixture was then cooled to room temperature and diluted with200 ml Et2O. The precipitate was isolated by filtration and washedsuccessively with EtOH and Et2O. The filter cake was dried in avacuum oven at 60 C overnight to yield 26.4 g (80%) of the titlecompound as off-white crystalline solid. ESI-MS m/z: 317.7[MNa]
77.4% With trichlorophosphate; In water monomer; at 20 - 70℃; for 12h; General procedure: To a three-necked flask, 5 (300mg, 0.61mmol), PPA (1.5g) and POCl3 (2.5g) were added at room temperature. The mixture was heated to 70C for 12h and then cooled to room temperature. The mixture was treated with aqueous Na2CO3 solution to remove the remanent acid and filtered, and the solid was washed with water and dried to afford the product, which could be used in next step. m.p. 211-212C; 1H NMR (400MHz, DMSO-d6): δ 12.80 (s, 1H, br), 10.92 (s, 1H), 8.60 (s, 1H), 8.56 (d, 1H, J=2.0Hz), 8.02 (dd, 1H, J1=8.7Hz, J2=2.0Hz), 7.80 (d, 1H, J=8.7Hz), 7.50 (t, 1H, J=7.7Hz), 7.36-7.45 (m, 3H), 4.24 (q, 2H, J=7.2Hz), 1.29 (t, 3H, J=7.2Hz); ESI-MS (m/z): 441 (M+H)+
In diphenylether;Reflux; General procedure: The quinolone derivatives 1 were prepared by treating the appropriate aniline (100 mmol) with diethyl ethoxymethylenemalonate (100 mmol) under reflux in ethanol (5 mL) for 2-10 h to obtain the enamine derivatives that were then cyclized in refluxing diphenyl ether for 30 min-6 h [29]. These quinolones (13 mmol) were refluxed in thionyl chloride (20 mL), for 17 h, affording the corresponding chloro-derivatives 2a-g [22]. Reaction of 2a-g (4 mmol) with 2-hydrazinobenzothiazole (8 mmol) in toluene (30 mL), for 3 h, followed by a 2 h reflux in acetic acid gave the corresponding 2-(benzo[d]thiazol-2-yl)-8-substituted-2H-pyrazolo[4,3-c]quinolin-3(5H)-ones 3a-g as solids which were collected by filtration under vacuum, washed with water and subsequent purified by washing with hot ethyl alcohol.
In diphenylether; for 1h;Reflux; General procedure: Substituted aniline 1 (0.01 mol) and diethylethoxy methylene malonate 2 (0.01 mol) weremixed and heated at 125-130 0C for 2 h. Ethanolwas evaporated off from the resulting mixture ofethyl anilinomethylene malonate 3. The crude solidwas filtered on sintered funnel, dried and recrystallized from n-hexane. The malonate 3 (0.01mol) was refluxed with diphenylether (50 mL) for 1h to give 1,4-dihydro-4-oxoquinoline-3-carboxylicacid ethyl ester 4. After 1 h the solution was cooledand the resulting precipitate was filtered off, washedwith n-hexane, and dried. The solid wasrecrystallized from DMF to give substituted-1,4-dihydro-4-oxoquinoline-3-carboxylic acid ethylester 4.
In diphenylether; at 240℃; for 1h;Dean-Stark; Diphenyl ether (870mL) was heated to 240C then diethyl 2-[[(4- bromophenyl)amino]methylidene]propanedioate (75g, 219.18mmol) added portionwise. The mixture was stirred at 240C for 60 minutes in a flask fitted with dean-stark apparatus. After cooling (25C) a crystallized solid was formed. The mixture was diluted with Et20 and the solid was collected by filtration, washed with Et20 and dried to afford the desired material (59.9g) as a beige crystallized solid, which was used without purification or characterisation.
In diphenylether; at 260℃; for 9.5h; Diphenyl ether (100 g) was then added to the crude solid and the mixture was refluxed at 260C for 8 hours. After 1.5 hours a white solid started crushing out of solution in the reaction flask. T.l.c. analysis (ethyl acetate cyclohexane, 1: 4) showed the presence of one UV-active product (Rf 0.75) andcomplete consumption of the intermediate starting material 1 (Rf 0.49). Upon cooling of the reaction solution to room temperature, more ethyl 6-bromo-4-oxo-1,4- dihydroquinoline-3-carboxylate 2 crushed out of solution as a white powder (at 230C). The white solid was filtered, washed with toluene and dried in vacuo to afford ethyl 6-bromo-4-oxo- 1 ,4-dihydroquinoline-3 -carboxylate 2 (2.5 87g, 43.4%) asa pale yellow/white powder. M.p. 285-290C (decomposition: gas evolved); HRMS(El): found 294.983 14 [M] C12H10NO379Br requires 294.98386; found 296.98073[M] C12H10NO381Br requires 296.98 152; peak ratio: 49.5% : 50.5%; Vmax (Ge): 3421(br s, NH), 3149, 3088 (w, ArC-H), 2981 (m, alkyl C-H), 1694 (s, 2 xintramolecularly hydrogen-bonded C=O conjugated with C=C), 1615 (s, CCconjugated with C=O) cm’; Elemental Analysis: found C 48.36%, H 3.34%, N 4.64%; required C 48.67%, H 3.40%, N 4.73%.
59.9 g In diphenylether; at 240℃; for 1h;Dean-Stark; Inert atmosphere; Diphenyl ether (870 mL) was heated to 240C then diethyl [(4- bromophenyl)amino]methylidene}propanedioate (75 g, 219.18 mmol) added portionwise. The mixture was stirred at 240C for 60 minutes in a flask fitted with Dean-Stark apparatus. After cooling ,the mixture was diluted with Et20 and the solid was collected by filtration, washed with Et20 and dried to afford ethyl 6-bromo-4-oxo-1H-quinoline-3-carboxylate (59.9g) as a beige crystallized solid, which was used without purification or characterisation.

Reference: [1]Patent: WO2009/40377,2009,A2 .Location in patent: Page/Page column 19
[2]Patent: WO2016/10869,2016,A2 .Location in patent: Page/Page column 16
[3]Patent: WO2017/11363,2017,A1 .Location in patent: Page/Page column 16
[4]ACS Medicinal Chemistry Letters,2017,vol. 8,p. 350 - 354
[5]European Journal of Medicinal Chemistry,2022,vol. 235
[6]European Journal of Medicinal Chemistry,2022,vol. 235
[7]European Journal of Medicinal Chemistry,2014,vol. 79,p. 413 - 421
[8]Bioorganic and Medicinal Chemistry,2018,vol. 26,p. 3967 - 3974
[9]Journal of Medicinal Chemistry,2006,vol. 49,p. 2526 - 2533
[10]Journal of Medicinal Chemistry,2006,vol. 49,p. 6443 - 6450
[11]Bioorganic and Medicinal Chemistry Letters,2006,vol. 16,p. 1010 - 1013
[12]Journal of Medicinal Chemistry,2008,vol. 51,p. 5075 - 5084
[13]Bioorganic and Medicinal Chemistry Letters,2010,vol. 20,p. 4649 - 4652
[14]Tetrahedron Letters,2010,vol. 51,p. 478 - 481
[15]European Journal of Medicinal Chemistry,2011,vol. 46,p. 1448 - 1452
[16]Bioorganic and Medicinal Chemistry Letters,2012,vol. 22,p. 5055 - 5058
[17]Oriental Journal of Chemistry,2013,vol. 29,p. 507 - 511
[18]Patent: WO2015/170081,2015,A1 .Location in patent: Page/Page column 66
[19]Patent: WO2015/189560,2015,A1 .Location in patent: Page/Page column 64; 65; 66
[20]Patent: WO2017/153578,2017,A1 .Location in patent: Page/Page column 43; 85; 86
[21]Journal of Enzyme Inhibition and Medicinal Chemistry,2019,vol. 34,p. 1457 - 1464
[22]Bioorganic and Medicinal Chemistry Letters,2020,vol. 30
[23]Bioorganic and Medicinal Chemistry,2020
[24]PeerJ,2020,vol. 2020
[25]New Journal of Chemistry,2020,vol. 44,p. 11203 - 11214
[26]Patent: EP3992191,2022,A1
  • 3
  • [ 122794-99-4 ]
  • [ 302553-00-0 ]
YieldReaction ConditionsOperation in experiment
99% With sodium hydroxide; In ethanol; water monomer; for 3h;Reflux; 77ml aqueous NaOH (2 N) were added at ambient temperature to asuspension of 15.2 g of the product from the previous step (51.2mmol) in 77 ml EtOH. The mixture was heated to reflux for 3 h andthen concentrated to approx. 50% of the starting volume. The yellowsolution was diluted with water and cooled with an ice bath.The mixture was acidified to pH 2 with hydrochloric acid to precipitatethe product. The resulting suspension was stirred for 10min at low temperature and was then filtered via a Buchner funnel.The filter cakewaswashed with H2O and dried in a convection ovenat 80 C to yield 13.5 g (99%) of the title compound as white solid. 1HNMR (200 MHz, DMSO) d 14.97 (br s, 1H), 13.56 (br s, 1H), 8.90 (s,1H), 8.30 (d, J 2.3 Hz, 1H), 8.00 (dd, J 8.9, 2.3 Hz, 1H), 7.75 (d, J 8.9 Hz, 1H) 13C NMR (50 MHz, DMSO) d 177.1, 166.0, 145.6, 138.4,136.6, 127.1, 125.9, 122.1, 119.0, 108.1. ESI-MS m/z: 265.6 [M H]-HPLC (Method A) tret 6.16 min.
99% With sodium hydroxide; In ethanol; water monomer; for 3h;Reflux; 77ml aqueous NaOH (2 N) were added at ambient temperature to asuspension of 15.2 g of the product from the previous step (51.2mmol) in 77 ml EtOH. The mixture was heated to reflux for 3 h andthen concentrated to approx. 50% of the starting volume. The yellowsolution was diluted with water and cooled with an ice bath.The mixture was acidified to pH 2 with hydrochloric acid to precipitatethe product. The resulting suspension was stirred for 10min at low temperature and was then filtered via a Buchner funnel.The filter cakewaswashed with H2O and dried in a convection ovenat 80 C to yield 13.5 g (99%) of the title compound as white solid. 1HNMR (200 MHz, DMSO) d 14.97 (br s, 1H), 13.56 (br s, 1H), 8.90 (s,1H), 8.30 (d, J 2.3 Hz, 1H), 8.00 (dd, J 8.9, 2.3 Hz, 1H), 7.75 (d, J 8.9 Hz, 1H) 13C NMR (50 MHz, DMSO) d 177.1, 166.0, 145.6, 138.4,136.6, 127.1, 125.9, 122.1, 119.0, 108.1. ESI-MS m/z: 265.6 [M H]-HPLC (Method A) tret 6.16 min.
96% With water monomer; sodium hydroxide; In ethanol; at 75℃; for 1.5h; 2N Sodium hydroxide (506mL, 1011.43mmol) was added to a stirred suspension of ethyl 6-bromo-4-oxo-lH-quinoline-3-carboxylate (59.9g, 202.29mmol) in EtOH (590mL) and the resulting solution stirred at 75C for 1.5 h. Water was added and the mixture cooled to 0C. The pH of the solution was adjusted to 3 using hydrochloric acid and the precipitate collected by filtration. The solid was washed with water, EtOH/water (1 : 1) then Et20 before being dried to afford the desired material (51.9g, 96%) as a beige solid. NMR Spectrum: 1H MR (500MHz, DMSO-d6) δ 7.80 (1H, d), 8.05 (1H, d), 8.37 (1H, s), 8.93 (1H, s). Mass Spectrum: m/z (ES+)[M+H]+ = 270.
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Related Functional Groups of
[ 122794-99-4 ]

Bromides

Chemical Structure| 35975-57-6

[ 35975-57-6 ]

Ethyl 8-bromo-4-hydroxyquinoline-3-carboxylate

Similarity: 0.88

Chemical Structure| 860205-92-1

[ 860205-92-1 ]

7-Bromo-4-hydroxyquinoline-3-carboxylic acid

Similarity: 0.84

Chemical Structure| 98948-95-9

[ 98948-95-9 ]

6-Bromo-4-hydroxyquinoline-3-carboxylic acid

Similarity: 0.84

Chemical Structure| 220844-77-9

[ 220844-77-9 ]

Ethyl 6-bromoquinoline-4-carboxylate

Similarity: 0.81

Chemical Structure| 481054-89-1

[ 481054-89-1 ]

Ethyl 6-bromoquinoline-3-carboxylate

Similarity: 0.81

Alcohols

Chemical Structure| 35975-57-6

[ 35975-57-6 ]

Ethyl 8-bromo-4-hydroxyquinoline-3-carboxylate

Similarity: 0.88

Chemical Structure| 860205-92-1

[ 860205-92-1 ]

7-Bromo-4-hydroxyquinoline-3-carboxylic acid

Similarity: 0.84

Chemical Structure| 98948-95-9

[ 98948-95-9 ]

6-Bromo-4-hydroxyquinoline-3-carboxylic acid

Similarity: 0.84

Chemical Structure| 318-35-4

[ 318-35-4 ]

Ethyl 6-fluoro-4-hydroxyquinoline-3-carboxylate

Similarity: 0.79

Chemical Structure| 26893-12-9

[ 26893-12-9 ]

Ethyl 4-hydroxy-6-(trifluoromethyl)quinoline-3-carboxylate

Similarity: 0.77

Esters

Chemical Structure| 35975-57-6

[ 35975-57-6 ]

Ethyl 8-bromo-4-hydroxyquinoline-3-carboxylate

Similarity: 0.88

Chemical Structure| 26892-90-0

[ 26892-90-0 ]

Ethyl 4-hydroxyquinoline-3-carboxylate

Similarity: 0.81

Chemical Structure| 220844-77-9

[ 220844-77-9 ]

Ethyl 6-bromoquinoline-4-carboxylate

Similarity: 0.81

Chemical Structure| 481054-89-1

[ 481054-89-1 ]

Ethyl 6-bromoquinoline-3-carboxylate

Similarity: 0.81

Chemical Structure| 318-35-4

[ 318-35-4 ]

Ethyl 6-fluoro-4-hydroxyquinoline-3-carboxylate

Similarity: 0.79

Related Parent Nucleus of
[ 122794-99-4 ]

Quinolines

Chemical Structure| 35975-57-6

[ 35975-57-6 ]

Ethyl 8-bromo-4-hydroxyquinoline-3-carboxylate

Similarity: 0.88

Chemical Structure| 860205-92-1

[ 860205-92-1 ]

7-Bromo-4-hydroxyquinoline-3-carboxylic acid

Similarity: 0.84

Chemical Structure| 98948-95-9

[ 98948-95-9 ]

6-Bromo-4-hydroxyquinoline-3-carboxylic acid

Similarity: 0.84

Chemical Structure| 220844-77-9

[ 220844-77-9 ]

Ethyl 6-bromoquinoline-4-carboxylate

Similarity: 0.81

Chemical Structure| 481054-89-1

[ 481054-89-1 ]

Ethyl 6-bromoquinoline-3-carboxylate

Similarity: 0.81

; ;